Aug 07, 2018 9:00 AM

Scientists at work in the Spike lab

SALT LAKE CITY- Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease. The findings were published today in Cell Reports. The study was led by Benjamin Spike, PhD, an HCI cancer researcher and assistant professor of oncological sciences at the U of U.

Scientists have recognized the relationship between normal organ development and cancer for more than 100 years. “We know that cancers are driven by mutations in specific genes that cause cells to multiply or to survive where they don’t belong,” said Spike. “During this process, cancer cells misappropriate whole circuitries of cell biology that are important and normal at other times in development. Our team works to understand this process by researching how cells normally work to form tissues. We also identify developmental programs that have been taken over by cancers. Some of these programs should make good targets for treating or preventing disease, even if they are not directly mutated.”

Until recently, tools didn’t exist that could simultaneously and individually analyze all of the different types of cells in an organ and their active genes, the segments of cellular DNA that encode functional molecules such as proteins.

Working with the lab of Geoffrey Wahl, PhD, professor at the Salk Institute, and others, Spike and his team isolated breast cells from mice during different stages of breast tissue development. The researchers then used new genome sequencing technology to analyze which genes are turned on and off in more than 6,000 individual cells during normal development. This approach revealed a list of hundreds of potentially critical genes for further study as regulators of normal and cancerous development. These genes may provide targets for certain breast cancers that don’t have molecular targeted therapies.

“This research promises new targets for these cancers, including genes involved in specialized cellular metabolism that are shared between early breast development and certain breast cancers,” said Spike. The data from the study gives new insights about the organizing principles of tissues and the molecular definitions of the cell types comprising them. The research shows that breast cells in early development that are not fully differentiated into mature cell types activate more genes, resulting in mixed profiles and expression of some genes in unexpected breast cell types.

With this new data resource, researchers are now working to determine how these genes and pathways promote cancer and identify new drugs to block them.  

The study was funded by the Huntsman Cancer Foundation, Breast Cancer Research Foundation, Susan G. Komen Foundation, Chapman Foundation, and Helmsley Charitable Trust, with additional support from the National Institutes of Health/National Cancer Institute (R35 CA1967687, P30 CA42014 and P30 CA014195).

Media Contact

Heather Simonsen
Public Relations – Huntsman Cancer Institute
Email Us
801 581-3194

cancer research breast cancer Cancer Center Research Program Cell Response and Regulation

About Huntsman Cancer Institute at the University of Utah

Huntsman Cancer Institute at the University of Utah is the official cancer center of Utah and the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West. The campus includes a state-of-the-art cancer specialty hospital and two buildings dedicated to cancer research. Huntsman Cancer Institute provides patient care, cancer screening, and education at community clinics and affiliate hospitals throughout the Mountain West. It is consistently recognized among the best cancer hospitals in the country by U.S. News and World Report. The region’s first proton therapy center opened in 2021 and a major hospital expansion is underway. Huntsman Cancer Institute is committed to creating a diverse and inclusive environment for staff, students, patients, and communities. Advancing cancer research discoveries and treatments to meet the needs of patients who live far away from a major medical center is a unique focus. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center, including genes responsible for breast, ovarian, colon, head and neck cancers, and melanoma. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.

Cancer touches all of us.

Share Your Story